Further Implications of Off-Label Use of Acetazolamide in the Management of Moyamoya Disease in Japan.

PubWeight™: 5.01‹?› | Rank: Top 1%

🔗 View Article (PMID 28628405)

Published in Radiology on July 01, 2017

Authors

Shunji Mugikura1, Miki Fujimura2, Shoki Takahashi1, Kei Takase1

Author Affiliations

1: Departments of Diagnostic Radiology * and.
2: Neurosurgery, † Graduate School of Medicine, Tohoku University, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan.